Clinical trials for Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion
10 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 3NCT07407803Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform NeurofibromasChia Tai Tianqing Pharmaceutical Group Co., Ltd.
- RECRUITINGN/ANCT07233408Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health LiteracyMassachusetts General Hospital · PI: Vanessa Merker, PhD
- RECRUITINGPhase 2NCT06188741Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1University of Alabama at Birmingham · PI: Karen Cole-Plourde, BA
- RECRUITINGN/ANCT06360406Real-World Treatment Study of Koselugo (Selumetinib)AstraZeneca · PI: AstraZeneca Clinical Study Information Center
- RECRUITINGPHASE1, PHASE2NCT06159166Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).Johns Hopkins University · PI: Carlos Romo, MD
- RECRUITINGPhase 1NCT06104488A Study of Avutometinib for People With Solid Tumor CancersMemorial Sloan Kettering Cancer Center · PI: Sameer Farouk Sait, MD
- ACTIVE NOT RECRUITINGPhase 1NCT05521048Doxycycline in Cutaneous Schwannoma (NF2)Massachusetts Eye and Ear Infirmary · PI: D. Bradley Welling, MD, PhD
- ACTIVE NOT RECRUITINGN/ANCT03873610Resiliency Training in Adolescents With NF1 and NF2Massachusetts General Hospital · PI: Ana-Maria Vranceanu, PhD
- RECRUITINGNCT04395495RASopathy BiorepositoryChildren's Hospital Medical Center, Cincinnati · PI: Kathryn N Weaver, MD
- RECRUITINGPhase 2NCT02728388Photodynamic Therapy for Benign Dermal Neurofibromas- Phase IIDonald Basel · PI: Donald G Basel, MD